Company Overview and News
Lexington Realty Trust (LXP) has been going through the often painful process of repositioning their portfolio since 2013. LXP is seeking to minimize their exposure to office properties in favor of single-tenant industrial properties.
SSREY NYSE GPT FDX SSREF
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BAMGF EDR BGX FCEA BGLF BX BGB FCE.B FCE.A GPT BAMKF BAM
Gramercy Property Trust (GPT - Free Report) just came out with quarterly earnings of $0.50 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.49 per share a year ago. These figures are adjusted for non-recurring items.
This is the third month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her dividend income totaled $891.57.
GIS WBA ENB OPRF JCI HSY ABBV MMM POL MO SMG DUKH GD TRV MAIN BX CMI ENB RY BNS JNJ TROW GPT VZ ABBV MSFT WPC ADM PFE CLX PM PFBC SKT SCL CTL IRET OXLCM OXLCO TD ETN OXLCN BNS CM MSCA INTC TD IBM RY TNTTF LYB O MSB DUK SNX OXLC IRM MSCA.CL EMRAF ORI PPL BMRC DLR CBL
In a recent Framework Investing Office Hour session, I spoke with one of Framework's members - hedge fund alum and New York City-based institutional investor, Robert Ruggirello, CFA - about a triple-net lease Real Estate Investment Trust called STORE Capital (NYSE:STOR). Robert's investment style was influenced by the work of the CIO of Yale College's Endowment, David Swenson, who suggests that a significant proportion of an investor's portfolio should be allocated to real assets.
STOR BRK.A O GPT
2018 has been one of the worst years for REIT investors since the great financial crisis. Market fear is back, and share prices have been dropping by ~10% on average since the beginning of the year:
VTR LHO O OPRF PLD GPT STAG PEB
This is the second month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her combined dividend income totaled $1,300.03.
ENB OPRF STI-A ABBV POL DUKH GD MAIN CMI ENB STI RY BNS JNJ GPT SPG WPC ABBV MSFT PFE PFBC CTL TD ETN BNS MSCA INTC TD IBM RY TNTTF O MSB DUK SNX MSCA.CL EMRAF ORI PPL DLR CBL
First off, let me start by saying that I am not here to determine whether Blackstone (BX) is a good investment today or not. To be fully honest, I do not know enough about the company to make my own opinion at this point. Rather, what I aim to do here is to highlight one of its latest acquisitions which is set to be completed in the second half of 2018.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
as of ET